
Is this your company?
Update it or Add a Logo
Logos place your company at the
top of the search results!
Edimer Pharmaceuticals is developing a drug to treat a rare disease called X-linked Hypohydrotic Ectodermal Dysplasia (XLHED).
Headlines from Mass High Tech about EDIMER PHARMACEUTICALS INC
Print this Listing
| Industry Classification | Biopharma/Biotechnology |
| Primary Business Focus | Biotechnology - Pharmaceutical |
| Year Established | 2009 |
| Ownership Type | Private |
| Neil Kirby | President/CEO | |||
| Jeff Behrens | Sr Director Business Dev't/Operations | email available to subscribers | ||
| Kenneth Huttner | Sr Director Clinical Research | |||
| Ramsey Johnson | Director Clinical Operations Director Clinical Op |
* Downloads will not contain Personnel E-mail addresses
| Focus | Biotechnology - Pharmaceutical |
| Location | Cambridge, MA |
| Website | http://www.edimerpharma.com |
| Revenue | Subscriber access only |
| Address |
1 Broadway 8th Floor Cambridge, MA, 02142 |
| Phone | 617-758-4300 |
| Fax | 866-334-4240 |
| Subscriber access only | |
| Website | www.edimerpharma.com |